P9881
溴化钾
ReagentPlus®, ≥99.0%
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
KBr
化学文摘社编号:
分子量:
119.00
NACRES:
NA.55
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
231-830-3
MDL number:
Assay:
≥99.0%
Form:
powder or crystals (or Chunks)
Quality Level
vapor pressure
<0.01 mmHg ( 20 °C), 1 mmHg ( 795 °C)
product line
ReagentPlus®
assay
≥99.0%
form
powder or crystals (or Chunks)
greener alternative product characteristics
Catalysis
Learn more about the Principles of Green Chemistry.
sustainability
Greener Alternative Product
pH
5-6 (25 °C, 119 g/L)
mp
734 °C (lit.)
greener alternative category
SMILES string
[K+].[Br-]
InChI
1S/BrH.K/h1H;/q;+1/p-1
InChI key
IOLCXVTUBQKXJR-UHFFFAOYSA-M
Application
可用于除去外周膜蛋白。
Features and Benefits
We are committed to bringing you Greener Alternative Products, which adhere to one or more of The 12 Principles of Greener Chemistry. This product is an environmentally benign and has been enhanced for catalytic efficiency. Click here for more information.
Other Notes
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC
Still not finding the right product?
Explore all of our products under 溴化钾
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2
存储类别
13 - Non Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Pascal Miéville et al.
Magnetic resonance in chemistry : MRC, 49(11), 689-692 (2011-10-18)
As previously demonstrated by Thurber and Tycko, the peak position of (79)Br in potassium bromide (KBr) allows one to determine the temperature of a spinning sample. We propose to adapt the original design by using a compact KBr tablet placed
Kazue Kurihara
Advances in colloid and interface science, 158(1-2), 130-138 (2010-05-11)
Brush layers of polyelectrolytes, ionized chains of poly(glutamic acid) (PLGA) and poly(lysine) (PLL), prepared by the Langmuir-Blodgett method, were characterized using the surface forces measurements at various pHs, salt concentrations and chain densities. This paper reviews the major results: (1)
Hitesh Kulhari et al.
Nanomedicine : nanotechnology, biology, and medicine, 11(6), 1511-1520 (2015-05-03)
Docetaxel (DTX) is an anticancer drug that is used alone and in combination with other drugs to treat tumours. However, it suffers from the drawback of non-specific cytotoxicity. To improve the therapeutic potential of DTX, we report the synthesis of
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| P9881-500G | 04061834405719 |
| P9881-1KG | 04061834405689 |